Malignancy can cause unexplained arterial thromboembolism in about 10% of patients. Investigating hypercoagulability in cancer patients and thromboembolism patients for malignancy is crucial for prevention.
You might also read
Articles linked to this work by shared authors, journal, and citation graph.
Area of Science:
Background:
Observation:
Findings:
Implications: